HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances

Go back to HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances
(NASDAQ: HCWB) Delayed: 4.33 -0.25 (5.46%)
Previous Close $4.58    52 Week High
Open $4.49    52 Week Low
Day High $4.74    P/E N/A 
Day Low $4.22    EPS
Volume 72,546       

(NASDAQ: HCWB) Delayed: 4.33 -0.25 (5.46%)
Previous Close $4.58    52 Week High
Open $4.49    52 Week Low
Day High $4.74    P/E N/A 
Day Low $4.22    EPS
Volume 72,546